Anti-neoplastic efficacy of Haimiding on gastric carcinoma and its mechanisms

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

390

HTML

2239

Figures (1-2)

281

Tables (1-12)

337

Sum=3247

Feb 15, 2004 (publication date) through Mar 13, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Feb 15, 2004; 10(4): 484-490
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.484

Table 10 Changes of intracellular [Ca²⁺]i in human gastric car-cinoma cells after treated with HMD for 36 h

^bP < 0.01,

^dP < 0.001 vs negative control;

^fP < 0.01 vs medium dose group and negative control group separately.

Citation: Ji YB, Gao SY, Ji HR, Kong Q, Zhang XJ, Yang BF. Anti-neoplastic efficacy of Haimiding on gastric carcinoma and its mechanisms. World J Gastroenterol 2004; 10(4): 484-490
URL: https://www.wjgnet.com/1007-9327/full/v10/i4/484.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i4.484